Abstract: Provided are a method and system of analyzing ingredients of an artificial rainfall for verification of a cloud seeding effect. As the method and system, which can verify an effect of the artificial rainfall in such a manner that a seeding material becomes different according to each temperature of clouds at a seeding altitude, water sampling from precipitation is performed before and after seeding, and thus the ingredients of a water sample are analyzed using each of a method of analyzing a heavy metal component and a method of analyzing a water-soluble ion component according to a cool cloud and a warm cloud so that whether or not there is a change in each concentration of the ingredients can be determined, are provided, an experiment for the artificial rainfall can more effectively be performed.

Abstract: The present invention relates to: a method for preparing a non-oxidized carbon nanotube dispersion through mechanical impregnation so as to apply carbon nanotubes having a hydrophobic surface and a bundle shape as a high-performance conductive material of a negative electrode or a positive electrode for a secondary battery through solvent dispersion without acid treatment; and a non-oxidized carbon nanotube dispersion for a conductive material of a secondary battery, prepared by the method.

Abstract: A display device includes pixels including a light-emitting element, and an initialization transistor connected between an anode electrode of the light-emitting element and a first initialization power line to which a voltage of initialization power is supplied, and turned on when an initialization scan signal is supplied, and an initialization scan driver which supplies the initialization scan signal. The initial scan driver supplies an i-th (i is a natural number) initial scan signal to overlap an (i?1)-th initial scan signal, and supplies an (i+1)-th initial scan signal so as not to overlap the i-th initial scan signal, and the initialization scan signal is set to a gate-on voltage.

Abstract: A composition includes mixed bacterial strains of Bacillus sp. pfbarrier 01 (KCTC 14628BP), Lactobacillus pentosus pfbio035 (KCTC 14684BP) and Lactobacillus sakei subsp. sakei pfbio005 (KCTC 14130BP), a culture solution thereof, or a compound extract thereof as an active ingredient to offer beneficial activities in improving skin wrinkles, moisturizing skin, strengthening skin barriers, and promoting regeneration of wounded skin. The composition poses non-cytotoxicity and high beneficial effects to improve skin wrinkles, moisturize skin, strengthen skin barriers, and help regeneration of wounded skin, which makes it highly applicable to the fields of foods and cosmetics. Besides, the composition is not only very safe for the human body but also has high stability.

Abstract: A secondary battery using a vanadium oxide as a positive electrode active material is provided. The secondary battery is prevented from degradation of capacity by preventing dissolution of vanadium. The vanadium oxide includes secondary particles formed by assemblage of primary particles.

Abstract: The present invention relates to a positive electrode for a secondary battery in which a maximum diameter of internal pores is controlled to be less than 1 ?m, a method of preparing the same, and a secondary battery including the positive electrode.

Abstract: Provided is an electrode, comprising: an electrode current collector, a metal nanowire formed on a surface of the electrode current collector, and a conductive layer surrounding the outside of the metal nanowire, wherein a gap is formed between the metal nanowire and the conductive layer, so that the metal nanowire and the conductive layer are spaced apart from each other without direct contact between them.

Abstract: A secondary battery using a vanadium oxide as a positive electrode active material is provided. The secondary battery is prevented from degradation of capacity by preventing dissolution of vanadium. The vanadium oxide includes secondary particles formed by assemblage of primary particles.

Abstract: Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.

Abstract: Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.

Abstract: The present invention relates to a positive electrode for a secondary battery in which a maximum diameter of internal pores is controlled to be less than 1 ?m, a method of preparing the same, and a secondary battery including the positive electrode.

Abstract: Provided is an immunogenic composition comprising 13 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from a different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, 12 serotypes selected from the group consisting of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F and serotype 2 or 9N. The immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases coverage with respect to pneumococcal diseases in infants and children.

Abstract: Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.

Abstract: Provided is an electrode, comprising: an electrode current collector, a metal nanowire formed on a surface of the electrode current collector, and a conductive layer surrounding the outside of the metal nanowire, wherein a gap is formed between the metal nanowire and the conductive layer, so that the metal nanowire and the conductive layer are spaced apart from each other without direct contact between them.

Abstract: The present disclosure relates to an anode active material-containing slurry, an anode using the slurry, and an electrochemical device comprising the anode. More specifically, the present disclosure relates to a slurry comprising an anode active material; a polymer binder comprising styrene butadiene rubber and potassium polyacrylate; a conductive material; and a dispersing medium, an anode using the slurry, and an electrochemical device comprising the anode. The anode active material-containing slurry according to one aspect of the present disclosure can relieve the volume expansion of an anode active material by the intercalation and disintercalation of lithium during cycles of electrochemical devices to improve the durability of an anode active material layer, thereby enhancing the life characteristics of the electrochemical devices, and can form an anode active material layer having a high peeling force even though potassium polyacrylate with a relatively lower weight-average molecular weight is used.

Abstract: Provided is an immunogenic composition comprising 13 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from a different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, 12 serotypes selected from the group consisting of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F and serotype 2 or 9N. The immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases coverage with respect to pneumococcal diseases in infants and children.

Abstract: The present disclosure relates to a binder solution for an anode, comprising a thermally cross-linkable polymer binder that is cross-linked by heat, and a solvent for dissolving the thermally cross-linkable polymer binder, and exhibiting a concentration of hydrogen ions corresponding to pH 2.5 to pH 4.5; an active material slurry for an anode, comprising the binder solution; an anode using the slurry; and an electrochemical device comprising the anode. The binder solution for an anode according to one aspect of the present disclosure can relieve the volume expansion of an anode active material by the intercalation and disintercalation of lithium during cycles of electrochemical devices to improve the durability of an anode active material layer, thereby enhancing the life characteristics of the electrochemical devices, and also can provide good dispersibility to the active material slurry for an anode, thereby improving the coating stability of an anode active material layer.

Abstract: Provided are an electrode binder for a secondary battery including an amine-based compound expressed by Chemical Formula 1 below and water-based binder particles including at least one carboxyl group as an end group, a method of preparing the same, and an electrode for a secondary battery including the electrode binder for a secondary battery

Abstract: Provided is an immunogenic composition comprising 13 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from a different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, 12 serotypes selected from the group consisting of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F and serotype 22F or 33F. The immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases coverage with respect to pneumococcal diseases in infants and children.

Abstract: Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from different serotype Streptococcus pneumoniae conjugated to a carrier protein, that is, serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F and 23F. An immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases application range with respect to pneumococcal diseases in infants and children.